CPNG vs NVZMY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CPNG · Coupang$16.29 ▼ 0.79%
NVZMY · NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10$68.83 ▼ 4.14%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CPNG -43.7%
- NVZMY +9.4%
Head to head
| Metric | CPNG | NVZMY |
|---|---|---|
| Price | $16.29 | $68.83 |
| Change today | ▼ 0.79% | ▼ 4.14% |
| Market cap | $29.20B | $29.20B |
| Return, 3 months | +0.6% | +5.5% |
| Return, year to date | -30.9% | +10.1% |
| Return, 1 year | -43.6% | +9.1% |
| P/E (TTM) | – | 40.5 |
| P/B | 10.3 | 2.6 |
| P/E percentile vs own 5y | 34th | – |
| Dividend yield | – | 1.48% |
| Revenue growth (YoY, latest qtr) | +7.5% | – |
| Net profit growth (YoY) | -627.4% | – |
| Gross margin | 27.4% | – |
| Operating margin | -3.4% | – |
| Net margin | -3.8% | – |
| Return on equity | -36.0% | – |
| Analyst target vs. price | +30.9% | – |
| Analyst buy share | 67% | – |
| RSI (14) | 63 | 51 |
| 30-day volatility | 49.3% | 27.0% |
| Max drawdown, 1 year | -57.2% | -20.0% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NVZMY is the largest of the group by market value.
- NVZMY has returned the most over the past year.
- NVZMY has been the calmest stock over the last 30 days.